Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer

被引:19
作者
Xu, Lan [1 ]
Verdoodt, Freija [1 ,2 ]
Wentzensen, Nicolas [3 ]
Bergeron, Christine [4 ]
Arbyn, Marc [1 ]
机构
[1] Sci Inst Publ Hlth, Canc Epidemiol Unit, Belgian Canc Ctr, Juliette Wytsmanstr 14, B-1050 Brussels, Belgium
[2] Danish Canc Soc, Res Ctr, Unit Virus Lifestyle & Genes, Copenhagen, Denmark
[3] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[4] Lab Cerba, Cergy Pontoise, France
关键词
atypical squamous cells; cannot exclude high-grade squamous intraepithelial lesion (ASC-H); cervical cancer; cervical intraepithelial neoplasia; diagnostic test accuracy; human papillomavirus (HPV); meta-analysis; triage; ATYPICAL SQUAMOUS-CELLS; PATHOLOGY SCREENING GUIDELINES; HUMAN-PAPILLOMAVIRUS GENOTYPES; GRADE INTRAEPITHELIAL LESION; AMERICAN-CANCER-SOCIETY; HYBRID-CAPTURE-II; FOLLOW-UP; 5-YEAR RISKS; UNDETERMINED SIGNIFICANCE; DIAGNOSTIC PERFORMANCE;
D O I
10.1002/cncy.21661
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDWomen with a cytological diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H) are usually immediately referred for colposcopy. However, triage may reduce the burden of the diagnostic workup and prevent overtreatment. METHODSA meta-analysis was conducted to assess the accuracy of high-risk human papillomavirus (hrHPV) testing and testing for other molecular markers for the detection of grade 2 cervical intraepithelial neoplasia or worse (CIN2+) or grade 3 cervical intraepithelial neoplasia or worse (CIN3+) in women with ASC-H. An additional question that was assessed was whether triage would be useful in light of the relatively high pretriage probability of underlying precancer. RESULTSThe pooled absolute sensitivity and specificity of the Hybrid Capture 2 (HC2) assay for CIN2+(derived from 19 studies) were 93% (95% confidence interval [CI], 89%-95%) and 45% (95% CI, 41%-50%), respectively. p16(INK4a) staining (only 3 studies) had similar sensitivity (93%; 95% CI, 75%-100%) but superior specificity (specificity ratio, 1.69) to HC2 for CIN2+. Testing for paired box 1 gene methylation (only 1 study) showed a superior specificity of 95% (specificity ratio, 2.08). The average pretest risk was 34% for CIN2+and 20% for CIN3+. A negative HC2 result decreased this to 8% and 5%, respectively, whereas a positive result upgraded the risk to 47% and 28%, respectively. CONCLUSIONSBecause of the high probability of precancer with a diagnosis of ASC-H, the utility of triage is limited. The usual recommendation for referring women with ASC-H for colposcopy is not altered by a positive triage test, whatever test is used. A negative hrHPV DNA or p16(INK4a) test may allow repeat testing, but this recommendation will depend on local decision thresholds for referral. Cancer Cytopathol 2016;124:261-72. (c) 2015 American Cancer Society. Because of the high probability of precancer in patients with a diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H), the utility of triage is limited. The usual recommendation of referring women with ASC-H to colposcopy is not altered by a positive triage test, whatever test is used. A negative high-risk human papillomavirus DNA or p16(INK4a) test may allow repeat testing, but this recommendation will depend on local decision thresholds for referral.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 60 条
[1]   Performance of proex c and pretect hpv-proofer e6/e7 mrna tests in comparison with the hybrid capture 2 hpv dna test for triaging ascus and lsil cytology [J].
Alaghehbandan, Reza ;
Fontaine, Daniel ;
Bentley, James ;
Escott, Nicholas ;
Ghatage, Prafull ;
Lear, Adrian ;
Coutlee, Francois ;
Ratnam, Samuel .
DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (09) :767-775
[2]  
[Anonymous], ACTA CYTOL
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   Worldwide burden of cervical cancer in 2008 [J].
Arbyn, M. ;
Castellsague, X. ;
de Sanjose, S. ;
Bruni, L. ;
Saraiya, M. ;
Bray, F. ;
Ferlay, J. .
ANNALS OF ONCOLOGY, 2011, 22 (12) :2675-2686
[5]   Use of HC2 to triage women with borderline and mild dyskaryosis in the UK [J].
Arbyn, M. ;
Roelens, J. ;
Martin-Hirsch, P. ;
Leeson, S. ;
Wentzensen, N. .
BRITISH JOURNAL OF CANCER, 2011, 105 (07) :877-880
[6]   Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis [J].
Arbyn, M. ;
Martin-Hirsch, P. ;
Wentzensen, N. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (06) :641-644
[7]   European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document [J].
Arbyn, M. ;
Anttila, A. ;
Jordan, J. ;
Ronco, G. ;
Schenck, U. ;
Segnan, N. ;
Wiener, H. ;
Herbert, A. ;
von Karsa, L. .
ANNALS OF ONCOLOGY, 2010, 21 (03) :448-458
[8]   Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis [J].
Arbyn, M. ;
Kyrgiou, M. ;
Simoens, C. ;
Raifu, A. O. ;
Koliopoulos, G. ;
Martin-Hirsch, P. ;
Prendiville, W. ;
Paraskevaidis, E. .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7673) :798-803
[9]   Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis [J].
Arbyn, Marc ;
Verdoodt, Freija ;
Snijders, Peter J. F. ;
Verhoef, Viola M. J. ;
Suonio, Eero ;
Dillner, Lena ;
Minozzi, Silvia ;
Bellisario, Cristina ;
Banzi, Rita ;
Zhao, Fang-Hui ;
Hillemanns, Peter ;
Anttila, Ahti .
LANCET ONCOLOGY, 2014, 15 (02) :172-183
[10]   Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer [J].
Arbyn, Marc ;
Ronco, Guglielmo ;
Anttila, Ahti ;
Meijer, Chris J. L. M. ;
Poljak, Mario ;
Ogilvie, Gina ;
Koliopoulos, George ;
Naucler, Pontus ;
Sankaranarayanan, Rengaswamy ;
Peto, Julian .
VACCINE, 2012, 30 :F88-F99